The limited duration of humoral responses to vaccination is a key issue in the fight against infectious diseases, as antibody levels wane over time, leaving individuals vulnerable to reinfection.
Stanford scientists have developed a cell-free method for producing high-purity plasmid DNA without the use of bacterial hosts. This approach eliminates contamination risks, reduces production time, and streamlines manufacturing for gene and cell therapies.
Stanford Medicine researchers in The Stuart Goodman Lab have developed a bone anchor system for surgical tracking that is easier to use and decreases complications caused by conventional knee or hip replacement bone pin anchors.
Stanford Artificial Retina Project researchers have developed an ASIC Retina Chip that interfaces with retinal ganglion cells to restore vision in patients with retinal degeneration.
Researchers at Stanford have identified amino acid modifications in the IgG Fc region which extend its therapeutic half-life and improve its in vivo receptor binding.
Researchers at Stanford have developed FiberFold, a computational tool enabling the rapid analysis of 3D chromatin architecture in conjunction with chromatin accessibility, CTCF binding, CpG methylation, and underlying genetic architecture.
The Stanford team has developed a Short Fiber Pre-Plied Double-Double (PPDD) Tape that can achieve complex, double-curvature composite parts like a helmet while maintaining high stiffness and other desired mechanical properties.
Stanford researchers have developed a new class of aryl ester RNA-reactive reagents that are stable for months in water yet rapidly modify RNA upon catalytic activation, enabling reliable, scalable tools for RNA research and therapeutic applications.
Stanford researchers have developed multivalent SIRP-alpha fusion polypeptides that selectively block the CD47–SIRP-alpha immune checkpoint with enhanced potency, enabling next-generation immunotherapies that promote immune clearance of cancer and diseased cells while minimizi
Stanford researchers have developed the Broadly Usable Multi-Pass Engineered Receptor (BUMPER) architecture, a novel protein engineering platform for assembling stable, multifunctional cell surface receptors.
Researchers in the Onori Lab have developed a state of charge (SOC) estimation technique for Lithium Iron Phosphate (LFP) batteries using machine learning.
Stanford scientists have developed species cross-reactive B7H3-targeting CAR-T cells that can effectively target both human and mouse tumors, enabling more accurate preclinical testing in immunocompetent models.